article thumbnail

Breaking down Biden's 2025 proposed budget: Here are his top health priorities

Fierce Healthcare

trillion budget for fiscal year 2025 on Monday, which continued upon and expanded key health items from previous years. Drug price negotiations and Medicare solvency were just two areas HHS officials hit upon while unveiling President Biden's 2025 fiscal year proposed budget. President Biden unveiled a proposed $7.3

135
135
article thumbnail

Payers up against slight decline in 2025 Medicare Advantage payments

Fierce Healthcare

Medicare Advantage (MA) payments are set to decrease yet again in 2025 as the feds phase in significant changes to risk adjustment. Medicare Advantage payments are set to decrease yet again in 2025 as the feds phase in significant changes to risk adjustment.

125
125
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Humana reaffirms 2025 guidance as CMS pitches decrease in MA benchmark payments

Fierce Healthcare

Humana reaffirmed its guidance in the face of likely cuts in Medicare Advantage payment rates for 2025, despite saying the proposed decrease was higher than it expected. Humana reaffirmed its guidance in the face of likely cuts in Medicare Advantage payment rates for 2025, despite saying the proposed decrease was higher than it expected.

97
article thumbnail

Cleveland Clinic to launch prescription delivery via drone in 2025, starting with specialty and rush medications

Fierce Healthcare

Cleveland Clinic plans to launch a drone delivery service to bring certain medications directly to patients’ homes, starting in 2025. | Cleveland Clinic plans to launch a drone delivery service to bring certain medications directly to patients’ homes, starting in 2025.

128
128
article thumbnail

Moderna eyes 2025 approval for COVID, flu combination jab

pharmaphorum

Moderna eyes 2025 approval for COVID, flu combination jab Phil.Taylor Thu, 05/10/2023 - 08:38 Bookmark this

105
105
article thumbnail

Biogen, working through a 'transition,' plots 1,000 more layoffs by 2025

Fierce Pharma

In a sizable cost-cutting measure, Biogen will lay off 1,000 employees by 2025, it announced in presenting its second quarter earnings. In reporting its first-quarter earnings, Biogen said it would halt the development of at least four investigational drugs to allow the company to focus on more lucrative opportunities. |

97
article thumbnail

Prilenia eyes 2025 launch for Huntington’s drug pridopidine

pharmaphorum

Prilenia Therapeutics is planning to file its Huntington’s disease drug pridopidine in the EU shortly, after mixed results in a phase 3 trial.

111
111